"What you'll be seeing from us in the future is really different ways of looking at problems, different ways of responding to clinical needs."

— Mark Bates, MD, founder/CEO of Nexeon, discussing the direction of what he terms his "physician-driven" company, "SurModics, Nexeon to make new stent for renal arteries."